Neurogenic potential of Ewing's sarcoma cells.
We investigated the capacity of eight well-characterized Ewing's sarcoma cell lines to differentiate towards a neural phenotype. Ewing's sarcoma cells expressed the neuroectoderm-associated antigens such as nerve growth factor (NGF) receptor, N-CAM (6H7 and Leu-19) and Leu-7. Ewing's sarcoma cells also exhibited the potential for neural differentiation at the mRNA level; neuron-specific medium- and low-sized filament (NF-M and NF-L) expression was induced by dibutyryladenosine cyclic monophosphate. The pattern of expression of NF-L obtained by using alternative polyadenylation sites in Ewing's sarcoma cells differed from that in peripheral primitive neuroectodermal tumour (PNET) cells, and was similar to that in undifferentiated neural tissues. Furthermore, the NGF receptors detected by immunohistochemistry were found to be non-functional as assayed by c-fos induction with NGF treatment. The results indicate that Ewing's sarcoma cells maintain a primitive phenotype and have the potential to differentiate into a neural phenotype, indicating that Ewing's sarcoma is distinct from PNET.
Sugimoto
T
T
Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Umezawa
A
A
Hata
J
J
D001859:Bone Neoplasms / Q000235:genetics / Q000473:pathology*; D002454:Cell Differentiation; D006801:Humans; D018242:Neuroectodermal Tumors, Primitive / Q000235:genetics / Q000473:pathology; D018241:Neuroectodermal Tumors, Primitive, Peripheral / Q000235:genetics / Q000473:pathology*; D010641:Phenotype; D012333:RNA, Messenger / Q000032:analysis; D012512:Sarcoma, Ewing / Q000235:genetics / Q000473:pathology*; D014407:Tumor Cells, Cultured
D012333:RNA, Messenger